Details for Patent: 10,828,298
✉ Email this page to a colleague
Which drugs does patent 10,828,298 protect, and when does it expire?
Patent 10,828,298 protects UPTRAVI and is included in one NDA.
This patent has twenty-five patent family members in twenty countries.
Summary for Patent: 10,828,298
| Title: | Pharmaceutical composition containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy]-N-(methylsu- lfonyl)acetamide |
| Abstract: | A stabilized solid preparation containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsu- lfonyl)acetamide is provided, namely, a solid preparation containing 2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}-N-(methylsu- lfonyl)acetamide and D-mannitol having a specific surface area of 1.0 m.sup.2/g or less. |
| Inventor(s): | Furuta; Shouji (Kyoto, JP), Mukai; Hironori (Kyoto, JP) |
| Assignee: | NIPPON SHINYAKU CO., LTD. (Kyoto, JP) |
| Application Number: | 16/044,821 |
|
Patent Claim Types: see list of patent claims | Use; Compound; Dosage form; |
Drugs Protected by US Patent 10,828,298
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actelion | UPTRAVI | selexipag | TABLET;ORAL | 207947-001 | Dec 21, 2015 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | METHOD OF TREATING PULMONARY ARTERIAL HYPERTENSION COMPRISING ADMINISTERING A TABLET CONTAINING SELEXIPAG | ⤷ Sign Up | ||
| Actelion | UPTRAVI | selexipag | TABLET;ORAL | 207947-002 | Dec 21, 2015 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | METHOD OF TREATING PULMONARY ARTERIAL HYPERTENSION COMPRISING ADMINISTERING A TABLET CONTAINING SELEXIPAG | ⤷ Sign Up | ||
| Actelion | UPTRAVI | selexipag | TABLET;ORAL | 207947-003 | Dec 21, 2015 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | METHOD OF TREATING PULMONARY ARTERIAL HYPERTENSION COMPRISING ADMINISTERING A TABLET CONTAINING SELEXIPAG | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,828,298
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2016366073 | ⤷ Sign Up | |||
| Brazil | 112018009534 | ⤷ Sign Up | |||
| Canada | 3005169 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
